MedPath
NMPA Approval

Sodium Nitroprusside for Injection

国药准字H20033674

November 6, 2020

Drug Information

注射用硝普钠

注射剂

50mg

化学药品

November 6, 2020

Company Information

Applicant Company

Manufacturing Company

湖南省岳阳经济技术开发区康王工业园

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用硝普钠 - NMPA 批准文号 | MedPath